BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35973790)

  • 1. Evaluation of State-Mandated Third Trimester Repeat HIV Testing in a Large Tertiary Care Center.
    Berhie SH; Tsai S; Miller ES; Garcia PM; Yee LM
    Am J Perinatol; 2024 Feb; 41(3):310-316. PubMed ID: 35973790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statewide Implementation of Universal Third-Trimester Repeat HIV Testing in Illinois.
    Yee LM; Ayala LD; Roach AM; Statton A; Randhawa S; Garcia PM; Miller ES
    Am J Perinatol; 2024 Feb; 41(3):241-247. PubMed ID: 37852273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-trimester repeat HIV testing: it is time we make it universal.
    Cassimatis IR; Ayala LD; Miller ES; Garcia PM; Jao J; Yee LM
    Am J Obstet Gynecol; 2021 Nov; 225(5):494-499. PubMed ID: 33932342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in state-mandated third-trimester testing for syphilis.
    Clement AC; Fay KE; Yee LM
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100595. PubMed ID: 35176505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Screening During Pregnancy in a U.S. HIV Epicenter.
    Szlachta-McGinn A; Aserlind A; Duthely L; Oldak S; Babriwala R; Montgomerie E; Potter J
    Infect Dis Obstet Gynecol; 2020; 2020():8196342. PubMed ID: 32454582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat antenatal HIV testing in the third trimester: a study of feasibility and maternal uptake rates.
    Williams B; Costello M; McHugh E; Le Prevost M; Phil-Ebosie A; Tilsed C; McSorley J; Murphy S; Brook G; Williams A
    HIV Med; 2014 Jul; 15(6):362-6. PubMed ID: 24215444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa.
    de Beer S; Kalk E; Kroon M; Boulle A; Osler M; Euvrard J; Timmerman V; Davies MA
    J Int AIDS Soc; 2020 Jan; 23(1):e25441. PubMed ID: 31997583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance study.
    Mussa A; Mayondi GK; Diseko M; Mabuta J; Mmalane M; Makhema J; Lockman S; Morroni C; Shapiro R; Zash R
    J Int AIDS Soc; 2023 Jan; 26(1):e26008. PubMed ID: 36691796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missed Opportunities for Repeat HIV Testing in Pregnancy: Implications for Elimination of Mother-to-Child Transmission in the United States.
    Liao C; Golden WC; Anderson JR; Coleman JS
    AIDS Patient Care STDS; 2017 Jan; 31(1):20-26. PubMed ID: 27936863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the rapid HIV test to rescreen women in the third trimester of pregnancy.
    Criniti SM; Aaron E; Levine AB
    J Midwifery Womens Health; 2009; 54(6):492-6. PubMed ID: 19879522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of repeat HIV testing during pregnancy in southwestern Kenya: progress and missed opportunities.
    Rogers AJ; Akama E; Weke E; Blackburn J; Owino G; Bukusi EA; Oyaro P; Kwena ZA; Cohen CR; Turan JM
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29236362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and clinical utility of repeated syphilis screening in the third trimester in a high-risk population.
    Shiber L; Todia WJ
    Am J Obstet Gynecol; 2014 Mar; 210(3):267.e1-5. PubMed ID: 24333235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency Virus Testing.
    Obstet Gynecol; 2018 Sep; 132(3):805-806. PubMed ID: 30134421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations.
    ACOG Committee on Obstetric Practice
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1119-24. PubMed ID: 15516421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Repeat Screening for Human Immunodeficiency Virus in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
    Hawkinson LF; Chaiken SR; Doshi U; Wallace J; Caughey AB
    Obstet Gynecol; 2023 Mar; 141(3):535-543. PubMed ID: 36800852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of large-for-gestational-age neonate by routine third-trimester ultrasound.
    Khan N; Ciobanu A; Karampitsakos T; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):326-333. PubMed ID: 31236963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
    Hersh AR; Megli CJ; Caughey AB
    Obstet Gynecol; 2018 Sep; 132(3):699-707. PubMed ID: 30095767
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.